Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations

The neurofibromatosis 2 (NF2) tumor suppressor gene product, merlin (schwannomin) forms an intramolecular association that is required for negative growth regulation in vitro and in vivo. In an effort to develop a molecular model for merlin relevant to its tumor suppressor function, we further characterized merlin intramolecular folding. We now demonstrate that merlin forms two intramolecular associations, one between the amino terminal (N‐term) domain and the carboxyl terminal (C‐term) domain and another within the amino terminal domain (N‐term/N‐term) itself. The N‐term/C‐term domain interaction requires contact between residues 302–308 in the N‐term and an intact exon 17 (residues 580–595) in the C‐term domain. In addition, we demonstrate that the N‐term/N‐term domain self‐interaction is required for N‐term/C‐term domain association. Lastly, we identify NF2 patient mutations that dramatically reduce each of these interactions in vitro. Based on these findings, we propose a model for merlin folding critical to its ability to function as a tumor suppressor protein. J. Neurosci. Res. 58:706–716, 1999. © 1999 Wiley‐Liss, Inc.

[1]  M. Hendrix,et al.  Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading. , 1999, Human molecular genetics.

[2]  N. Ratner,et al.  Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells , 1998, Oncogene.

[3]  Agnieszka Sidor,et al.  NHE3 Kinase A Regulatory Protein E3KARP Binds the Epithelial Brush Border Na+/H+ Exchanger NHE3 and the Cytoskeletal Protein Ezrin* , 1998, Journal of Biological Chemistry.

[4]  T. Jacks,et al.  Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. , 1998, Genes & development.

[5]  S. Pulst,et al.  Neurofibromatosis 2 tumour suppressor schwannomin interacts with βII-spectrin , 1998, Nature Genetics.

[6]  T. Jacks,et al.  Regulation of the Neurofibromatosis Type 2 Tumor Suppressor Protein, Merlin, by Adhesion and Growth Arrest Stimuli* , 1998, The Journal of Biological Chemistry.

[7]  D. Gutmann,et al.  Defects in neurofibromatosis 2 protein function can arise at multiple levels. , 1998, Human molecular genetics.

[8]  K. Kaibuchi,et al.  Rho-Kinase Phosphorylates COOH-terminal Threonines of Ezrin/Radixin/Moesin (ERM) Proteins and Regulates Their Head-to-Tail Association , 1998, The Journal of cell biology.

[9]  D. Gutmann,et al.  Merlin differentially associates with the microtubule and actin cytoskeleton , 1998, Journal of neuroscience research.

[10]  J. Gusella,et al.  NHE-RF, a Regulatory Cofactor for Na+-H+Exchange, Is a Common Interactor for Merlin and ERM (MERM) Proteins* , 1998, The Journal of Biological Chemistry.

[11]  D. Louis,et al.  Universal absence of merlin, but not other ERM family members, in schwannomas. , 1997, The American journal of pathology.

[12]  D. Gutmann,et al.  Interdomain binding mediates tumor growth suppression by the NF2 gene product , 1997, Oncogene.

[13]  A. Bretscher,et al.  Identification of EBP50: A PDZ-containing Phosphoprotein that Associates with Members of the Ezrin-Radixin-Moesin Family , 1997, The Journal of cell biology.

[14]  J. Jääskeläinen,et al.  Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. , 1997, Journal of cell science.

[15]  P. Mangeat,et al.  A Dual Involvement of the Amino-terminal Domain of Ezrin in F- and G-actin Binding* , 1997, The Journal of Biological Chemistry.

[16]  P. Mangeat,et al.  Three determinants in ezrin are responsible for cell extension activity. , 1997, Molecular biology of the cell.

[17]  D. Gutmann,et al.  Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas , 1997, Neurology.

[18]  D. Gutmann,et al.  Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules , 1997, Brain Research.

[19]  S. Pulst,et al.  Immunohistochemical Detection of Schwannomin and Neurofibromin in Vestibular Schwannomas, Ependymomas and Meningiomas , 1997, Journal of neuropathology and experimental neurology.

[20]  Satoshi O. Suzuki,et al.  Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study , 1997, Acta Neuropathologica.

[21]  V. Sundaram,et al.  Reduced Expression of Schwannomin/Merlin in Human Sporadic Meningiomas , 1997 .

[22]  J. Kimura,et al.  Cyclin-dependent Kinase 5 in Lewy Body-like Inclusions in Anterior Horn Cells of a Patient with Sporadic Amyotrophic Lateral Sclerosis , 1997, Neurology.

[23]  D. Gutmann,et al.  Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells , 1996, Journal of neuroscience research.

[24]  T. Sasaki,et al.  Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway , 1996, The Journal of cell biology.

[25]  J. Gusella,et al.  The merlin tumor suppressor localizes preferentially in membrane ruffles. , 1996, Oncogene.

[26]  S. Pulst,et al.  Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. , 1996, Oncogene.

[27]  A. Bretscher,et al.  Ezrin oligomers are major cytoskeletal components of placental microvilli: a proposal for their involvement in cortical morphogenesis , 1995, The Journal of cell biology.

[28]  T. H. van der Kwast,et al.  Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. , 1995, The American journal of pathology.

[29]  F. Solomon,et al.  Interdomain Interactions of Radixin in Vitro(*) , 1995, The Journal of Biological Chemistry.

[30]  A. Bretscher,et al.  Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. , 1995, Molecular biology of the cell.

[31]  G. Rouleau,et al.  The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. , 1995, Cancer research.

[32]  F. Solomon,et al.  Molecular dissection of radixin: distinct and interdependent functions of the amino- and carboxy-terminal domains , 1995, The Journal of cell biology.

[33]  J. Gusella,et al.  An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). , 1994, The Journal of biological chemistry.

[34]  N. Sato,et al.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons , 1994, The Journal of cell biology.

[35]  S. Pulst,et al.  Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. , 1994, Human molecular genetics.

[36]  A. Bretscher,et al.  Heterotypic and homotypic associations between ezrin and moesin, two putative membrane-cytoskeletal linking proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Pulst,et al.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.

[38]  J. Haines,et al.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.

[39]  E. R. Kandel,et al.  Synaptic transmission: A bidirectional and self-modifiable form of cell-cell communication , 1993, Cell.

[40]  R Eldridge,et al.  Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). , 1988, The New England journal of medicine.